I want to quickly point out two short selling/put option purchasing opportunities. Although, significant intraday drop in share price had already taken place, I believe there's still room to the downside.
VVUS jumped 16.3% following announcement of 2-year follow-up clinical trial data, showing patients experiencing reduced blood pressure from VVUS' experimental obesity drug. Intraday drop already amounted to 10% and there's more room to drop. Apr $7 put options surged 218% from the falling stock off of today's peak. Read more about Vivus announcement.
Orexigen, a direct competitor of Vivus in the diet pill arena, also soared 22% following announcement of follow-up clinical trial data, showing patients benefiting from sustained weight loss of >10% for more than two years. Intraday drop already added to 6.6% and more share dumping is expected in the next few days. Apr $3 put options surged as high as 300% from the falling stock off of today's peak. Read more about OREX press release.
My OREX Apr $3 put option order was filled at $0.05 (9:40 am PT).
ReplyDeleteAbove options sold for $0.10 on Apr 8 - 100% return on sliding OREX price =)
ReplyDeleteSlim-Fizz is a unique appetite suppressant which is containing the groundbreaking fibre Glucomannan, which is a natural dissolvable fibre extracted from high quality fresh Konjac.
ReplyDelete